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Background. Recently, we described the discovery of a novel group 2 coronavirus, coronavirus HKU1 (CoV-
HKU1), from a patient with pneumonia. However, the clinical and molecular epidemiological features of CoV-
HKU1–associated pneumonia are unknown.
Methods. Prospectively collected (during a 12-month period) nasopharyngeal aspirates (NPAs) from patients
with community-acquired pneumonia from 4 hospitals were subjected to reverse-transcription polymerase chain
reaction, for detection of CoV-HKU1. The epidemiological, clinical, and laboratory characteristics of patients with
CoV-HKU1–associated pneumonia were analyzed. The pol, spike (S), and nucleocapsid (N) genes were also sequenced.
Results. NPAs from 10 (2.4%) of 418 patients with community-acquired pneumonia were found to be positive
for CoV-HKU1. All 10 cases occurred in spring and winter. Nine of these patients were adults, and 4 had underlying
diseases of the respiratory tract. In the 6 patients from whom serum samples were available, all had a 4-fold change
in immunoglobulin (Ig) G titer and/or presence of IgM against CoV-HKU1. The 2 patients who died had sig-
nificantly lower hemoglobin levels, monocyte counts, albumin levels, and oxygen saturation levels on admission
and had more-extensive involvement visible on chest radiographs. Sequence analysis of the pol, S, and N genes
revealed 2 genotypes of CoV-HKU1.
Conclusions. CoV-HKU1 accounts for 2.4% of community-acquired pneumonia, with 2 genotypes in the
study population. Without performance of diagnostic tests, the illness was clinically indistinguishable from other
community-acquired pneumonia illnesses.
Since no microbiological cause can be identified in a
significant proportion of patients with respiratory tract
infections [1, 2], research has been conducted to iden-
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tify novel agents. Of the 3 novel agents identified in
the last 3 years—including human metapneumovirus
[3], severe acute respiratory syndrome (SARS) corona-
virus (SARS-CoV) [4], and human coronavirus NL63
(HCoV-NL63) [5, 6]—2 are coronaviruses. On the basis
of serological and phylogenetic characterization, co-
ronaviruses were divided into 3 distinct groups: human
coronavirus 229E (HCoV-229E) and HCoV-NL63 are
group 1 coronaviruses, and human coronavirus OC43
(HCoV-OC43) is a group 2 coronavirus [7]. HCoV-
229E and HCoV-OC43 account for 5%–30% of hu-
man respiratory tract infections [8], whereas, in a few
recent studies, HCoV-NL63 was found to be present in
2%–3.6% of respiratory specimens [9–11]. In 2002 and
2003, the epidemic caused by SARS-CoV affected18000
people, with 750 deaths [4, 12–18].
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Table 1. Primers used for amplification and sequencing of the pol, spike (S), and nucleocapsid (N) genes.
Gene Forward primer Reverse primer
pol LPW1465 5′-GTTCAAGTGTCGCTGTTCA-3′ LPW1822 5′-CTATCATTATCACAATCCACAG-3′
LPW1467 5′-GGGTATGAAGTATCATCCTA-3′ LPW1825 5′-GATAATCCCAACCCATAAGAAC-3′
LPW1826 5′-CATCTTATAAAGGATGTTGAC-3′ LPW1829 5′-ACAAACAACACATGCACCTACAC-3′
S LPW1830 5′-TTGCCTATTATTTTACAAGGT-3′ LPW1864 5′-ACACTACCTATAACTATAGTAC-3′
LPW1832 5′-TATGTTAATAAWACTTTGTATAGTG-3′ LPW1866 5′-TACAATTGACAAGAACTAGAAG-3′
LPW1836 5′-GATTTGCARTTGGGCAGTTCTGG-3′ LPW1868 5′-CCATTAGAATCATACAAAAGAT-3′
LPW1840 5′-GGTATTTTTAAAGAAGTTTCTGC-3′ LPW1870 5′-AGCTTCAACAAAACCWACATCTG-3′
LPW1844 5′-TAGGTYCACAMTGYGGTTCTTC-3′ LPW1872 5′-AMCCTTGYTTAGGTGCAATACCT-3′
LPW1848 5′-TTAAAACTGTYTTAGTAAGTCC-3′ LPW1874 5′-TAGTAAAACTAGTTAYAACACC-3′
N LPW1887 5′-TAGTGGTATGGATACTGCCTTGT-3′ LPW1890 5′-GCTTTAACATTTCAGMATTACCA-3′
LPW1891 5′-CAGTGTTTTGGTAAAAGAGGACC-3′ LPW1892 5′-TACCACCTAGTGTCGAATTAGG-3′
Figure 1. Phylogenetic tree of pol gene sequences of the 10 coronavirus HKU1 (CoV-HKU1) specimens from patients with community-acquired pneumonia.
The tree was inferred from pol gene data by the neighbor-joining method, and bootstrap values were calculated from 1000 trees. The tree was rooted
using the pol gene sequence of human coronavirus 229E (HCoV-229E), and 393 nt positions (primer sequences excluded) in each pol gene were included
in the analysis. The scale bar indicates the estimated no. of substitutions per 50 bases using the Jukes-Cantor correction. BCoV, bovine coronavirus; HCoV-
OC43, human coronavirus OC43; MHV, murine hepatitis virus; PHEV, porcine hemagglutinating encephalomyelitis virus.
Recently, we have described the discovery of a novel group
2 coronavirus, coronavirus HKU1 (CoV-HKU1), from a patient
with pneumonia [19]. Complete genome sequencing and phy-
logenetic analysis revealed that CoV-HKU1 is a distinct group
2 coronavirus, with G + C content of 32%, the lowest among
all known coronaviruses. Although preliminary screening also
identified an additional patient with pneumonia with CoV-
HKU1 in her nasopharyngeal aspirate (NPA), the epidemio-
logical and clinical features of CoV-HKU1–associated pneu-
monia remain to be determined. In the present study, using
prospectively collected NPAs, we examined the prevalence of
CoV-HKU1 in patients with community-acquired pneumonia
during a 12-month period. The clinical, laboratory, and radi-
ological characteristics of patients with CoV-HKU1–associated
pneumonia were described. The molecular epidemiological pro-
file of CoV-HKU1 was also analyzed.
PATIENTS AND METHODS
Patients and microbiological methods. All prospectively col-
lected NPAs from patients with community-acquired pneu-
monia that were sent to the clinical microbiology laboratories
of 4 hospitals in Hong Kong during a 12-month period (22
March 2003 [the beginning of the SARS epidemic in Hong
Kong] to 21 March 2004) for detection of SARS-CoV and were
found to be negative for SARS-CoV RNA, by reverse-tran-
scription polymerase chain reaction (RT-PCR) [20], were in-
cluded in the study. Community-acquired pneumonia is de-
Table 2. Epidemiological, clinical, and radiological characteristics of patients with community-acquired pneumonia associated with coronavirus HKU1.
Characteristic
Patient
1 2 3 4 5 [19] 6 7 8 9 10
Month/year Mar/2003 Apr/2003 May/2003 Jan/2004 Jan/2004 Jan/2004 Jan/2004 Jan/2004 Mar/2004 Mar/2004
Sex/age, years F/35 M/66 M/13 M/75 M/71 F/96 M/78 M/68 F/83 M/72
Ethnic origin Chinese Arabian Chinese Chinese Chinese Chinese Chinese Chinese Chinese Chinese
Underlying disease(s)  Diabetes mellitus,
old myocardial
infarction, gastric
lymphoma
Asthma, situs
inversus,
dextrocardia
Hypertension Chronic obstructive
airway disease,
hyperlipidemia,
abdominal aortic
aneurysm
Hypertension Chronic obstructive
airway disease,
diabetes mellitus
 Chronic obstructive
airway disease,
parathyroid
adenoma,
dementia
Prostate carcinoma,
cerebrovascular
accident, diabetes
mellitus
History of travel within 2
weeks of disease
onset
  Shenzhen, China Guangdong, China Shenzhen, China   Guangdong, China  
History of smoking    + +  +  + +
Clinical feature
Fever +  +  + + + + + +
Chills     +     
Rigor          
Myalgia          
Headache     +     
Cough +  + + +  + +  +
Sputum production   + + +  + +  +
Dyspnea  +  +   + + + +
Pleurisy          
Rhinorrhea     +     
Sore throat +    +     
Oxygen saturation level
on room air, %
99 83 100 99 99 97 97 95 99 88
Chest radiograph features RLZ airspace
shadows
Bilateral airspace
shadows
LMZ and LLZ
airspace
shadows
LLZ airspace
shadows
LLZ airspace
shadows
RLZ airspace
shadows
LLZ airspace
shadows
RMZ airspace
shadows
RLZ airspace
shadows
Bilateral airspace
shadows
Outcome Survived Died Survived Survived Survived Survived Survived Survived Survived Died
Duration of hospitalization,
no. of days
2 Died on day 12 3 7 5 7 13 5 6 Died on day 6
NOTE. +, present; , absent; LLZ, left lower zone; LMZ, left middle zone; LUZ, left upper zone; RLZ, right lower zone; RMZ, right middle zone; RUZ, right upper zone.
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Table 3. Comparison of clinical, laboratory, and radiological characteristics of
patients with coronavirus HKU1 (CoV-HKU1)–associated pneumonia and those of age-
and sex-matched controls with non–CoV-HKU1–associated pneumonia.
Characteristic
Pneumoniaa
P
CoV-HKU1
(n p 10)
Non-CoV-HKU1
(n p 20)
Underlying diseases 8 12 .42
History of travel within 2 weeks of disease onset 4 6 .69
History of smoking 5 7 .46
Clinical features
Fever 8 14 .68
Cough 7 17 .37
Sputum production 6 12 1.00
Dyspnea 6 6 .12
Rhinorrhea 1 2 1.00
Sore throat 2 2 .58
Hematological feature
Hemoglobin concentration, g/dL 12.4 13.2 .27
Leukocyte count, 109 leukocytes/L 9.9 9.7 .95
Neutrophil count, 109 neutrophils/L 7.35 7.4 .71
Lymphocyte count, 109 lymphocytes/L 0.95 1.02 .48
Monocyte count, 109 monocytes/L 0.55 0.65 .35
Platelet count, 109 platelets/L 240 292 .20
Serum biochemical features
Sodium concentration, mmol/L 136 137 .59
Potassium concentration, mmol/L 3.9 4.0 .42
Creatinine concentration, mmol/L 92 76.5 .06
Urea concentration, mmol/L 5.25 4.9 .62
Albumin concentration, g/L 37 38 .59
Globulin concentration, g/L 36.5 30 .07
Bilirubin concentration, mmol/L 12 10 1.00
ALT concentration, U/L 20 17 .42
Alkaline phosphatase concentration, U/L 102 91 .95
Oxygen saturation level on room air, % 96 98 .86
Radiological feature
Bilateral involvement 2 5 1.00
No. of zones involved 1 1 .81
Mortality 2 0 .10
NOTE. ALT, alanine aminotransferase.
a Continuous variables are expressed as medians, and categorical variables are expressed as the no.
of patients with the presence of the characteristic.
fined as symptoms and signs, consistent with an acute lower
respiratory tract infection and associated with new radiographic
finding for which there is no other explanation, that develop
before or within 48 h after presentation to the hospital. Once
CoV-HKU1 was detected in NPAs, hospital records, laboratory
results (including direct antigen detection, by immunofluores-
cence, of influenza A and B viruses, parainfluenza viruses 1–
3, respiratory syncytial virus [RSV], and adenovirus [21]), and
chest radiographs of the corresponding patients were analyzed
by 2 infectious-disease physicians. The RNA extracted from the
NPAs was subjected to RT-PCR, for detection of influenza A
virus and human metapneumovirus [4]. Available stored serum
samples were subjected to serological assays, for detection of
antibodies against Mycoplasma, Chlamydia, and Legionella spe-
cies and SARS-CoV, by SERODIA-MYCO II (Fujirebio), Chla-
mydia pneumoniae MIF IgG (Focus Technologies), indirect im-
munofluorescence (MRL), and our recently developed ELISA,
respectively [16].
To determine possible risk factors associated with CoV-
HKU1–associated pneumonia, 2 age- and sex-matched controls
per patient with CoV-HKU1–associated pneumonia were ran-
domly selected from patients with community-acquired pneu-
monia whose NPAs were found to be negative for CoV-HKU1.
Controls were within 5 years in age (older or younger) of the
corresponding patients with CoV-HKU1–associated pneumo-
nia and were admitted within 15 days before or after admission
of the corresponding patients with CoV-HKU1–associated pneu-
monia. The hospital records, laboratory results, and chest ra-
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Figure 2. Chest radiographs of the 2 patients who died of coronavirus
HKU1–associated community-acquired pneumonia. The chest radiograph of
the first patient (A) (patient 2 in table 2) showed patchy airspace shadows
in both lungs, with predominant involvement of the lower zones. The chest
radiograph of the second patient (B) (patient 10 in table 2), with Luque
instrumentation in situ, showed extensive airspace shadows in both lungs,
with the middle zones more severely involved.
diographs of the controls were examined by 2 infectious disease
physicians.
RNA extraction. Viral RNA was extracted from NPAs using
the QIAamp Viral RNA Mini Kit (QIAgen) within 10 h of
receipt of specimens. The eluted RNA (template for RT-PCR)
was stored immediately at 70C until use.
RT-PCR of the pol gene of CoV-HKU1 using CoV-HKU1–
specific primers and DNA sequencing. A 453-bp fragment of
the pol gene of CoV-HKU1 was amplified by RT-PCR using
CoV-HKU1–specific primers (LPW1926 [5′-AAAGGATGTTG-
ACAACCCTGTT-3′] and LPW1927 [5′-ATCATCATACTAAA-
ATGCTTACA-3′]) designed by multiple alignment of the nu-
cleotide sequences of the pol genes of CoV-HKU1 [19] and
those of other coronaviruses. RT was performed using the Su-
perScript II kit (Invitrogen). The PCR mixture (50 mL) con-
tained cDNA, PCR buffer, 200 mmol/L each dNTP, and 1.0 U
of Taq polymerase (Boehringer). The mixtures were amplified
in 40 cycles of 94C for 1 min, 48C for 1 min, and 72C for
1 min and a final extension at 72C for 10 min. To ensure the
high specificity of the CoV-HKU1–specific primers, RNA ex-
tracted from 200 NPAs positive for influenza A and B viruses,
parainfluenza viruses 1–3, RSV, or adenovirus antigens and
RNA from 12 NPAs positive for HCoV-229E, HCoV-OC43,
HCoV-NL63, or SARS-CoV RNA (3 samples/coronavirus) were
also subjected to RT-PCR using the 2 CoV-HKU1–specific prim-
ers. The amplified products were detected by agarose gel elec-
trophoresis, as described elsewhere [19].
Both strands of the PCR products were sequenced twice by
use of an ABI Prism 3700 DNA Analyzer (Applied Biosystems),
using the 2 PCR primers. The sequences of the PCR products
were compared with the sequences of the pol genes of CoV-
HKU1 [19] and those of other coronaviruses in the GenBank
database.
ELISA using recombinant nucleocapsid (N) protein of CoV-
HKU1. The ELISA-based IgG and IgM antibody tests were
performed in accordance with our published protocol [19].
Each sample was tested in duplicate, and the mean absorbance
for each serum sample was calculated.
RT-PCR and sequencing of the complete pol, spike (S), and
N genes of CoV-HKU1 and phylogenetic analysis. The com-
plete pol, S, and N genes of CoV-HKU1 from NPAs from 9 of
the 10 patients from whom adequate amounts of RNA were
available were amplified and sequenced using the strategy de-
scribed in our previous study [19] and the primers listed in
table 1. The nucleotide and deduced amino acid sequences of
the pol, S, and N genes were compared with those of CoV-
HKU1 [19] and other group 2 coronaviruses. Phylogenetic tree
construction was performed using the PileUp method with
GrowTree (Genetics Computer Group).
Statistical analysis. A comparison of characteristics was
made between patients with CoV-HKU1–associated pneumonia
and those with non–CoV-HKU1–associated pneumonia and
between patients who died of and those who survived CoV-
HKU1–associated pneumonia. Fisher’s exact test was used for
categorical variables, and the Mann-Whitney U test was used
for continuous variables. was regarded as statisticallyP ! .05
significant.
RESULTS
Clinical and laboratory characteristics. During the 12-month
period, NPAs from 418 patients (men:women, 198:220; mean
SD age, years) in 4 hospitals with community-ac-49 26
quired pneumonia were found to be negative for SARS-CoV RNA
by RT-PCR. A 453-bp fragment of the pol gene of CoV-HKU1
was amplified and sequenced for 10 patients (2.4%). Sequence
analysis revealed 0%–2% nucleotide differences between the se-
quences of the fragments and the sequence of the pol gene from
CoV-HKU1–Associated Pneumonia • JID 2005:192 (1 December) • 1903
Table 4. Comparison of clinical, laboratory, and radiological characteristics of
patients who survived and those who died of coronavirus HKU1–associated pneumonia.
Characteristic
Outcomea
P
Survived
(n p 8)
Died
(n p 2)
Sex, M:F 5:3 2:0 1.00
Age, years 73 69 .60
Underlying diseases 6 2 .45
History of travel within 2 weeks of disease onset 4 0 .24
History of smoking 4 1 1.00
Clinical features
Fever 7 1 .26
Cough 6 1 .51
Sputum production 5 1 .76
Dyspnea 4 2 .22
Rhinorrhea 1 0 .62
Sore throat 2 0 .45
Hematological feature
Hemoglobin concentration, g/dL 13.4 9 .04b
Leukocyte count, 109 leukocytes/L 9.7 7.85 .43
Neutrophil count, 109 neutrophils/L 7.4 6.9 .79
Lymphocyte count, 109 lymphocytes/L 1.35 0.55 .15
Monocyte count, 109 monocytes/L 0.7 0.3 .04b
Platelet count, 109 platelets/L 292 200.5 .79
Serum biochemical feature
Sodium concentration, mmol/L 137.5 134 .11
Potassium concentration, mmol/L 3.9 4.5 .06
Creatinine concentration, mmol/L 79 76.5 .69
Urea concentration, mmol/L 4.6 10.75 .19
Albumin concentration, g/L 38.5 26 .04b
Globulin concentration, g/L 30 30 1.00
Bilirubin concentration, mmol/L 10 30.5 .79
ALT concentration, U/L 16.5 30.5 .36
Alkaline phosphatase concentration, U/L 86 190.5 .07
Oxygen saturation level on room air, % 99 85.5 .03b
Radiological feature
Bilateral involvement 0 2 .003b
No. of zones involved 1 6 .01b
NOTE. ALT, alanine aminotransferase.
a Continuous variables are expressed as medians, and categorical variables are expressed as the no.
of patients with the presence of the characteristic.
b Difference is statistically significant.
the CoV-HKU1 in the NPAs from the reported index patient
(patient 5) [19] (figure 1). In contrast, by use of our CoV-HKU1–
specific primers, none of the 200 NPAs positive for influenza A
and B viruses, parainfluenza viruses 1–3, RSV, or adenovirus
antigens and none of the 12 NPAs positive for HCoV-229E,
HCoV-OC43, HCoV-NL63, and SARS-CoV RNA were RT-PCR
positive.
The epidemiological, clinical, and radiological characteristics
of the 10 patients with CoV-HKU1–associated community-ac-
quired pneumonia are summarized in table 2. No epidemio-
logical linkage was identified among the 10 cases. All cases
occurred during either spring or winter (January–May). The
median age of these patients was 71.5 years (range, 13–96 years).
Seven were men, and 3 were women. Eight had underlying
diseases, of whom 4 had underlying diseases of the respiratory
tract. Four had recently traveled to southern China. Five were
smokers. Clinically, the illness was not distinguishable from
other community-acquired pneumonia illnesses. Fever, pro-
ductive cough, and dyspnea were common symptoms at pre-
sentation. Upper respiratory tract symptoms were present in
only 2 patients (patients 1 and 5). One patient (patient 7) had
loose-stool diarrhea. Oxygen saturation levels on room air on
admission were !95% in 2 patients. Airspace shadows were
observed in the right lungs of 6 patients and in the left lungs
of 6 patients. The upper, middle, and lower zones were affected
in 2, 4, and 9 patients, respectively. All patients, except patient
Figure 3. Phylogenetic trees and nonsynonymous mutations and corresponding amino acid changes of complete pol, spike (S), and nucleocapsid (N) gene sequences of coronavirus HKU1 (CoV-HKU1)
specimens from 9 patients with community-acquired pneumonia. The trees were inferred from pol (3A), S (3B), and N (3C) gene data by the neighbor-joining method, and bootstrap values were calculated
from 1000 trees. The trees were rooted using pol, S, and N gene sequences of human coronavirus OC43 (HCoV-OC43). A total of 2784 nt positions in each pol gene, 4071 nt positions in each S gene, and
1326 nt positions in each N gene were included in the analysis. The scale bar indicates the estimated no. of substitutions per 100 (A) and 50 (B and C) bases, using the Jukes-Cantor correction. The shaded
nucleotides are those that differ from the majority at the corresponding location. Because of the large no. of nonsynonymous mutations in the S gene, only the NH2 terminal 45, of a total of 306 nonsynonymous
mutations, is shown.
CoV-HKU1–Associated Pneumonia • JID 2005:192 (1 December) • 1905
Figure 4. Distribution of nonsynonymous mutations in the spike (S) gene of coronavirus HKU1 (CoV-HKU1). The S protein (1356 aa) of CoV-HKU1 is
depicted by the horizontal bar, and the positions of the nonsynonymous mutations are depicted by vertical lines in the bar. HR1, heptad repeat 1 (aa 982–
1083); HR2, heptad repeat 2 (aa 1250–1297); SS, N terminal signal sequence (aa 1–13); TM, transmembrane domain (aa 1301–1323).
10, had normal platelet counts and normal results of liver and
renal function tests. Bacterial or mycobacterial pathogens were
not detected in any of the sputum samples from the patients.
Results of direct antigen testing for influenza A and B viruses,
parainfluenza viruses 1–3, RSV, and adenovirus and of RT-PCR
for influenza A virus and metapneumovirus were negative for
all NPAs. Results of testing for antibodies against Mycoplas-
ma pneumoniae, C. pneumoniae, Chlamydia psittaci, Legionella
pneumophila, and SARS-CoV were negative for all 6 patients
(patients 1, 4, 5, 6, 8, and 9) from whom serum samples were
available. Of these 6 patients, all had a 4-fold increase in IgG
titer (patients 4, 5, and 6) and/or the presence of IgM against
CoV-HKU1 (patients 1, 5, 8, and 9). Compared with age- and
sex-matched controls with non–CoV-HKU1–associated pneu-
monia, patients with CoV-HKU1–associated pneumonia had
no epidemiological, clinical, hematological, serum biochemical,
or radiological risk factors identified (table 3). None of the 10
patients in this control group from whom serum samples were
available had a 4-fold increase in IgG titer or the presence of
IgM against CoV-HKU1.
Two of the 10 patients died of CoV-HKU1–associated pneu-
monia. The first patient (patient 2) was a 66-year-old man who
had presented with dyspnea for 1 day. He had type 2 diabetes
mellitus, old myocardial infarction, and gastric lymphoma with
total gastrectomy in 2002 and was treated with chemotherapy.
He had severe lymphopenia ( lymphocytes/L) and an90.2 10
oxygen saturation level of only 83% on admission. Chest ra-
diographic examination revealed patchy airspace shadows in
both lungs, with predominant involvement of the lower zones
(figure 2A). He died 11 days after admission. The other patient
(patient 10) was a 72-year-old man who had presented with
fever and productive cough for 1 week. He had type 2 diabetes
mellitus, cerebrovascular accident, and prostatic carcinoma with
bone metastasis complicated by spinal cord compression; lam-
inectomy and Luque instrumentation were performed. He had
lymphopenia ( lymphocytes/L), thrombocytopenia90.9 10
( thrombocytes/L), deranged liver and renal function933 10
test results, and an oxygen saturation level of only 88% on
admission. Chest radiographic examination revealed extensive
airspace shadows in both lungs, with the middle zones more
severely involved (figure 2B). He died 5 days after admission.
The clinical, laboratory, and radiological characteristics of pa-
tients who survived and those who died of CoV-HKU1–associ-
ated community-acquired pneumonia were compared (table 4).
Patients who died had lower hemoglobin concentrations (Pp
.04), monocyte counts (Pp .04), serum albumin levels (Pp
.04), and oxygen saturation levels on admission (Pp .03) and
had bilateral involvement ( ) and more zones involvedPp .003
( ) on chest radiographs.Pp .01
RT-PCR and sequencing of the complete pol, S, and N genes
of CoV-HKU1 and phylogenetic analysis. The complete pol,
S, and N genes of CoV-HKU1 from NPAs from 9 of the 10
patients from whom adequate amounts of RNA were avail-
able were amplified and sequenced. The phylogenetic trees and
nonsynonymous mutations and the corresponding amino acid
changes are shown in figure 3. For the S gene, there were 317
and 306 nt positions with synonymous and nonsynonymous
mutations, respectively (figure 3B); 72% and 28% of the non-
synonymous mutations were in the putative S1 and S2, re-
spectively (figure 4). For the N gene, there were 42 and 53 nt
positions with synonymous and nonsynonymous mutations,
respectively (figure 3C). The nucleotide sequences of 7 of the
9 S or N genes showed similar sequences (genotype A), and
those of the other 2 genes also showed similar sequences (ge-
notype B) (figure 3B and 3C). For the CoV-HKU1 specimen
from patient 1, 2 peaks (T and C) were consistently observed
at nt 1300 of the N gene, suggesting the presence of a quasi
species (figure 3C). For the pol gene, there were 95 and 13 nt
positions with synonymous and nonsynonymous mutations,
respectively (figure 3A). The nucleotide sequences of the pol
genes in the 7 CoV-HKU1 specimens of genotype A were also
clustered together (figure 3A). Interestingly, the 7 CoV-HKU1
specimens of genotype A were from 7 patients with underlying
diseases, and the 2 specimens of genotype B were from the 2
patients without underlying diseases (table 2). Furthermore,
multiple alignments of the nucleotide sequences of the pol genes
from the 9 CoV-HKU1 specimens and those from the HCoV-
OC43, HCoV-229E, HCoV-NL63, and SARS-CoV supported
the notion that the primers used in the present study were
specific for CoV-HKU1.
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DISCUSSION
CoV-HKU1, a novel group 2 coronavirus, is associated with
community-acquired pneumonia. Since the SARS epidemic in
2003, we have started to prospectively collect NPAs from pa-
tients with community-acquired pneumonia and store the ex-
tracted RNA, so that, when a novel virus is discovered, the
epidemiological and, hence, the clinical, laboratory, and radi-
ological features of the disease can be studied in a timely man-
ner. In January 2004, we discovered a novel coronavirus, CoV-
HKU1, from a patient with community-acquired pneumonia
[19]. The RNA extracted from prospectively collected NPAs
was immediately retrieved, and the presence of CoV-HKU1 was
investigated. Ten of the 418 NPAs were positive for CoV-HKU1,
giving an incidence of 2.4%. The presence of CoV-HKU1 in
these specimens was genuine—that is, it was not due to con-
tamination—since amplification and sequencing of multiple
genes (pol, S, and N) of CoV-HKU1 indicated the presence of
CoV-HKU1 with different nucleotide sequences from the dif-
ferent patients. Moreover, the clinical significance of CoV-HKU1
was confirmed by the presence of a specific antibody response
in all 6 patients from whom serum samples were available. The
antibody response in these patients was unlikely to be the result
of cross-reaction with other known human coronaviruses, since
none of the 20 serum samples obtained from patients with
HCoV-OC43 infections or SARS-CoV pneumonia had positive
results in the recombinant N ELISA (authors’ unpublished
data). Further studies on detection of CoV-HKU1 in NPAs from
healthy individuals will determine whether asymptomatic shed-
ding of CoV-HKU1 occurs.
Similar to HCoV-229E, HCoV-OC43, and HCoV-NL63,
CoV-HKU1 is a human coronavirus that is endemic in hu-
mans. Similar to other human coronavirus infections, cases of
CoV-HKU1–associated pneumonia occurred during winter and
spring. Most patients with CoV-HKU1–associated pneumonia
were old (80% were 165 years old) and had major underlying
diseases, especially those of the respiratory and cardiovascular
systems. To study the phylogeny and relationships among the
10 CoV-HKU1 specimens, we sequenced the pol, S, and N genes
from the 9 CoV-HKU1 specimens that contained adequate
amounts of RNA. Combined with the data on partial sequenc-
ing of the pol genes from the 10 CoV-HKU1 specimens (figure
1), results showed that, unlike the epidemiological profile of
SARS-CoV, the 10 CoV-HKU1 specimens were not clonal, and
the topology of the phylogenetic trees did not follow the pattern
of a clonal outbreak (figure 3). Interestingly, the phylogenetic
trees constructed using the sequences of both the S and N genes
showed that CoV-HKU1 of genotype B was detected in NPAs
from with 2 patients without underlying diseases, but CoV-
HKU1 of genotype A was detected in NPAs from patients with
underlying diseases (figure 3B and 3C). Sequencing of more
CoV-HKU1 specimens may reveal the presence of genotypes
or clades of CoV-HKU1 with differential virulence.
Compared with SARS-CoV pneumonia, CoV-HKU1–associ-
ated pneumonia is a monophasic disease, and most patients
had relatively mild symptoms that were localized to the respi-
ratory tract and were, therefore, hospitalized only briefly. SARS-
CoV pneumonia is often described as a biphasic disease, with
the first phase due to cell lysis as a result of viral replication
and the second phase due to immunopathological damage [4,
12]. On the other hand, all 10 patients with CoV-HKU1–as-
sociated pneumonia showed the pattern of a monophasic dis-
ease. Although dyspnea was present in one-half of the patients
with CoV-HKU1–associated pneumonia at presentation, com-
pared with only ∼20% of patients with SARS-CoV pneumonia
at presentation [4], patients with CoV-HKU1–associated pneu-
monia often recovered quickly, but patients with SARS-CoV
pneumonia deteriorated after 7–10 days [4, 12]. For the 8 pa-
tients who recovered, the median duration of hospitalization
was only 5.5 days. This rapid recovery of patients with CoV-
HKU1–associated pneumonia could be related to the rapid con-
trol of the virus by the immune system. This is in line with
the results of our previous study, which showed that the index
patient with CoV-HKU1–associated pneumonia had his peak
viral load at around day 3 after the onset of illness [19]. More-
over, only 1 of the patients had extrapulmonary symptoms, and
all available extrapulmonary specimens (stool, urine, and se-
rum) were negative, by RT-PCR, for CoV-HKU1 (authors’ un-
published data). On the other hand, for SARS-CoV pneumonia,
patients usually had their peak viral loads 7–10 days after onset
of illness [12]. Furthermore, the virus can be readily detected
in extrapulmonary specimens, in which the viral loads corre-
lated with the manifestations in the corresponding systems [22].
These findings imply that the virus was not well controlled by
the immune system during the initial phase of the illness.
Despite the relatively mild course of disease in most patients,
CoV-HKU1–associated pneumonia is associated with mortality
in a minority of patients who have lower hemoglobin concen-
trations, monocyte counts, serum albumin levels, and oxygen
saturation levels on admission and more-extensive involvement
on chest radiographs. As in most cases of pneumonia, extensive
involvement in the lungs will result in poor gaseous exchange
and, hence, hypoxia and eventually death. The lower hemo-
globin concentrations, monocyte counts, and serum albumin
levels could represent poorer premorbid states and narrower
margins to fight against infections. Both patients who died had
underlying diabetes mellitus, malignancy (gastric lymphoma in
one and prostate carcinoma in the other), and cardiovascular
disease (old myocardial infarction in one and cerebrovascular
accident in the other).
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